RATIONALE: Low birth weight is associated with an increased risk of wheezing in childhood. OBJECTIVES: We examined the associations of longitudinally measured fetal and infant growth patterns with the risks of asthma symptoms in preschool children. METHODS: This study was embedded in a population-based prospective cohort study among 5,125 children. Second- and third-trimester fetal growth characteristics (head circumference, femur length, abdominal circumference, and weight) were estimated by repeated ultrasounds. Infant growth (head circumference, length, and weight) was measured at birth and at the ages of 3, 6, and 12 months. Parental report of asthma symptoms until the age of 4 years was yearly obtained by questionnaires. MEASUREMENTS AND MAIN RESULTS: Both fetal restricted and accelerated growth, defined as a negative or positive change of more than 0.67 standard deviation score, were not associated with asthma symptoms until the age of 4 years. Accelerated weight gain from birth to 3 months following normal fetal growth was associated with increased risks of asthma symptoms (overall odds ratio for wheezing: 1.44 [95% confidence interval: 1.22, 1.70]; shortness of breath: 1.32 [1.12, 1.56]; dry cough: 1.16 [1.01, 1.34]; persistent phlegm: 1.30 [1.07, 1.58]), but not with eczema (0.95 [0.80, 1.14]). These associations were independent of other fetal growth patterns and tended to be stronger for children of atopic mothers than for children of nonatopic mothers. CONCLUSIONS: Weight-gain acceleration in early infancy was associated with increased risks of asthma symptoms in preschool children, independent of fetal growth. Early infancy might be a critical period for the development of asthma.
RATIONALE: Low birth weight is associated with an increased risk of wheezing in childhood. OBJECTIVES: We examined the associations of longitudinally measured fetal and infant growth patterns with the risks of asthma symptoms in preschool children. METHODS: This study was embedded in a population-based prospective cohort study among 5,125 children. Second- and third-trimester fetal growth characteristics (head circumference, femur length, abdominal circumference, and weight) were estimated by repeated ultrasounds. Infant growth (head circumference, length, and weight) was measured at birth and at the ages of 3, 6, and 12 months. Parental report of asthma symptoms until the age of 4 years was yearly obtained by questionnaires. MEASUREMENTS AND MAIN RESULTS: Both fetal restricted and accelerated growth, defined as a negative or positive change of more than 0.67 standard deviation score, were not associated with asthma symptoms until the age of 4 years. Accelerated weight gain from birth to 3 months following normal fetal growth was associated with increased risks of asthma symptoms (overall odds ratio for wheezing: 1.44 [95% confidence interval: 1.22, 1.70]; shortness of breath: 1.32 [1.12, 1.56]; dry cough: 1.16 [1.01, 1.34]; persistent phlegm: 1.30 [1.07, 1.58]), but not with eczema (0.95 [0.80, 1.14]). These associations were independent of other fetal growth patterns and tended to be stronger for children of atopic mothers than for children of nonatopic mothers. CONCLUSIONS: Weight-gain acceleration in early infancy was associated with increased risks of asthma symptoms in preschool children, independent of fetal growth. Early infancy might be a critical period for the development of asthma.
Authors: Niloufar Farzan; Susanne J Vijverberg; Anand K Andiappan; Lambang Arianto; Vojko Berce; Natalia Blanca-López; Hans Bisgaard; Klaus Bønnelykke; Esteban G Burchard; Paloma Campo; Glorisa Canino; Bruce Carleton; Juan C Celedón; Fook Tim Chew; Wen Chin Chiang; Michelle M Cloutier; Denis Daley; Herman T Den Dekker; F Nicole Dijk; Liesbeth Duijts; Carlos Flores; Erick Forno; Daniel B Hawcutt; Natalia Hernandez-Pacheco; Johan C de Jongste; Michael Kabesch; Gerard H Koppelman; Vangelis G Manolopoulos; Erik Melén; Somnath Mukhopadhyay; Sara Nilsson; Colin N Palmer; Maria Pino-Yanes; Munir Pirmohamed; Uros Potočnik; Jan A Raaijmakers; Katja Repnik; Maximilian Schieck; Yang Yie Sio; Rosalind L Smyth; Csaba Szalai; Kelan G Tantisira; Steve Turner; Marc P van der Schee; Katia M Verhamme; Anke H Maitland-van der Zee Journal: Pharmacogenomics Date: 2017-06-22 Impact factor: 2.533
Authors: Laura Polányi; Carien M Niessen; Christina Vohlen; Julia Stinn; Tobias Kretschmer; Vanessa Jentgen; Dharmesh Hirani; Silke V Koningsbruggen-Rietschel; Jörg Dötsch; Miguel A Alejandre Alcazar Journal: J Mol Med (Berl) Date: 2020-01-07 Impact factor: 4.599
Authors: Yi Ying Ong; Suresh Anand Sadananthan; Izzuddin M Aris; Mya Thway Tint; Wen Lun Yuan; Jonathan Y Huang; Yiong Huak Chan; Sharon Ng; See Ling Loy; Sendhil S Velan; Marielle V Fortier; Keith M Godfrey; Lynette Shek; Kok Hian Tan; Peter D Gluckman; Fabian Yap; Jonathan Tze Liang Choo; Lieng Hsi Ling; Karen Tan; Li Chen; Neerja Karnani; Yap-Seng Chong; Johan G Eriksson; Mary E Wlodek; Shiao-Yng Chan; Yung Seng Lee; Navin Michael Journal: Int J Epidemiol Date: 2020-10-01 Impact factor: 7.196
Authors: Katharine C Pike; Hazel M Inskip; Sian M Robinson; Cyrus Cooper; Keith M Godfrey; Graham Roberts; Jane S A Lucas Journal: Thorax Date: 2013-01-03 Impact factor: 9.139
Authors: Samuel A Collins; Katharine C Pike; Hazel M Inskip; Keith M Godfrey; Graham Roberts; John W Holloway; Jane S A Lucas Journal: Pediatr Pulmonol Date: 2013-02-08
Authors: Emma L Anderson; Abigail Fraser; Richard M Martin; Michael S Kramer; Emily Oken; Rita Patel; Kate Tilling Journal: Pediatr Allergy Immunol Date: 2013-02-03 Impact factor: 6.377